<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Macular Degeneration &#187; Medicines</title>
	<atom:link href="http://www.curemaculardegeneration.com/tag/medicines/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.curemaculardegeneration.com</link>
	<description>Offers information on macular degeneration, or AMD, and also how to stop age related macular degeneration.</description>
	<lastBuildDate>Thu, 04 Mar 2010 23:00:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon</title>
		<link>http://www.curemaculardegeneration.com/9757/potentia-pharmaceuticals-enters-into-licensing-and-purchase-option-agreements-with-alcon/</link>
		<comments>http://www.curemaculardegeneration.com/9757/potentia-pharmaceuticals-enters-into-licensing-and-purchase-option-agreements-with-alcon/#comments</comments>
		<pubDate>Fri, 23 Oct 2009 05:00:00 +0000</pubDate>
		<dc:creator>Technorati Search for: "macular degeneration"</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[Alcon Pharmaceuticals]]></category>
		<category><![CDATA[amd]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Louisville Kentucky]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Option Agreements]]></category>
		<category><![CDATA[Path]]></category>
		<category><![CDATA[Pot]]></category>
		<category><![CDATA[Potentia Pharmaceuticals]]></category>
		<category><![CDATA[Purchase Option]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/potentia-pharmaceuticals-enters-into-licensing-and-purchase-option-agreements-with-alcon-7929/</guid>
		<description><![CDATA[LOUISVILLE, Kentucky -  – Alcon takes over development of POT-4 as a treatment for patients with age-related macular degeneration  – Deal provides path for Alcon to acquire Potentia Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered into licensing and purchase option agreements with [...]]]></description>
			<content:encoded><![CDATA[LOUISVILLE, Kentucky -  – Alcon takes over development of POT-4 as a treatment for patients with age-related macular degeneration  – Deal provides path for Alcon to acquire Potentia Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered into licensing and purchase option agreements with [...]]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/9757/potentia-pharmaceuticals-enters-into-licensing-and-purchase-option-agreements-with-alcon/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy marketing: Potentia Pharmaceuticals&#039; POT-4 Drug Candidate &#8230;</title>
		<link>http://www.curemaculardegeneration.com/5481/pharmacy-marketing-potentia-pharmaceuticals-pot-4-drug-candidate/</link>
		<comments>http://www.curemaculardegeneration.com/5481/pharmacy-marketing-potentia-pharmaceuticals-pot-4-drug-candidate/#comments</comments>
		<pubDate>Fri, 08 May 2009 11:03:00 +0000</pubDate>
		<dc:creator>aeckneupfw</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[amd]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Drug Candidate]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[Pot]]></category>
		<category><![CDATA[Potentia Pharmaceuticals]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://167fda309b021f4cf8db0b56523873b2</guid>
		<description><![CDATA[Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced that it successfully completed its Phase I ASaP (Assessment of Safety of ...]]></description>
			<content:encoded><![CDATA[Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced that it successfully completed its Phase I ASaP (Assessment of Safety of ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/5481/pharmacy-marketing-potentia-pharmaceuticals-pot-4-drug-candidate/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacy ce: Potentia Pharmaceuticals&#039; POT-4 Drug Candidate For &#8230;</title>
		<link>http://www.curemaculardegeneration.com/5477/pharmacy-ce-potentia-pharmaceuticals-pot-4-drug-candidate-for/</link>
		<comments>http://www.curemaculardegeneration.com/5477/pharmacy-ce-potentia-pharmaceuticals-pot-4-drug-candidate-for/#comments</comments>
		<pubDate>Thu, 07 May 2009 13:09:00 +0000</pubDate>
		<dc:creator>ahqldefgde</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[amd]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Drug Candidate]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Pharmacy Ce]]></category>
		<category><![CDATA[Pot]]></category>
		<category><![CDATA[Potentia Pharmaceuticals]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://a44473344e50e3cc1f22999da0065da1</guid>
		<description><![CDATA[Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced that it successfully completed its Phase I ASaP (Assessment of Safety of <b>...</b>]]></description>
			<content:encoded><![CDATA[Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced that it successfully completed its Phase I ASaP (Assessment of Safety of <b>...</b>]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/5477/pharmacy-ce-potentia-pharmaceuticals-pot-4-drug-candidate-for/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmacies in mexico: Potentia Pharmaceuticals&#039; POT-4 Drug &#8230;</title>
		<link>http://www.curemaculardegeneration.com/5464/pharmacies-in-mexico-potentia-pharmaceuticals-pot-4-drug/</link>
		<comments>http://www.curemaculardegeneration.com/5464/pharmacies-in-mexico-potentia-pharmaceuticals-pot-4-drug/#comments</comments>
		<pubDate>Wed, 06 May 2009 17:09:00 +0000</pubDate>
		<dc:creator>jfrcnaugus</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[amd]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Pharmacies In Mexico]]></category>
		<category><![CDATA[Pharmacies Mexico]]></category>
		<category><![CDATA[Pot]]></category>
		<category><![CDATA[Potentia Pharmaceuticals]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://c45558ecb2582f9fdac11b0d2e31fa0c</guid>
		<description><![CDATA[Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced that it successfully completed its Phase I ASaP (Assessment of Safety of <b>...</b>]]></description>
			<content:encoded><![CDATA[Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced that it successfully completed its Phase I ASaP (Assessment of Safety of <b>...</b>]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/5464/pharmacies-in-mexico-potentia-pharmaceuticals-pot-4-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Foreign pharmacies: Potentia Pharmaceuticals&#039; POT-4 Drug Candidate &#8230;</title>
		<link>http://www.curemaculardegeneration.com/5451/foreign-pharmacies-potentia-pharmaceuticals-pot-4-drug-candidate/</link>
		<comments>http://www.curemaculardegeneration.com/5451/foreign-pharmacies-potentia-pharmaceuticals-pot-4-drug-candidate/#comments</comments>
		<pubDate>Tue, 05 May 2009 22:27:00 +0000</pubDate>
		<dc:creator>okvfpvoasl</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[amd]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Drug Candidate]]></category>
		<category><![CDATA[Foreign Pharmacies]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Pot]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://5a10279f9a0f61afa159e004989ac900</guid>
		<description><![CDATA[Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced that it successfully completed its Phase I ASaP (Assessment of Safety of <b>...</b>]]></description>
			<content:encoded><![CDATA[Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced that it successfully completed its Phase I ASaP (Assessment of Safety of <b>...</b>]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/5451/foreign-pharmacies-potentia-pharmaceuticals-pot-4-drug-candidate/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>esjreserch: Enema</title>
		<link>http://www.curemaculardegeneration.com/4207/esjreserch-enema/</link>
		<comments>http://www.curemaculardegeneration.com/4207/esjreserch-enema/#comments</comments>
		<pubDate>Sun, 19 Apr 2009 05:53:00 +0000</pubDate>
		<dc:creator>es.j.5</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Digestive Tract]]></category>
		<category><![CDATA[Enema]]></category>
		<category><![CDATA[Enemas]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medicines]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://bdaf5cb900ecb5fee27af69618d8864f</guid>
		<description><![CDATA[Medicines for cancer, for arthritis, and for age-related <b>macular degeneration</b> are often given via enema in order to avoid the normally-functioning digestive tract. Interestingly, some water-based enemas are also used as a relieving <b>...</b>]]></description>
			<content:encoded><![CDATA[Medicines for cancer, for arthritis, and for age-related <b>macular degeneration</b> are often given via enema in order to avoid the normally-functioning digestive tract. Interestingly, some water-based enemas are also used as a relieving <b>...</b>]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/4207/esjreserch-enema/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MEDICINES REMEDIES</title>
		<link>http://www.curemaculardegeneration.com/3408/medicines-remedies/</link>
		<comments>http://www.curemaculardegeneration.com/3408/medicines-remedies/#comments</comments>
		<pubDate>Mon, 13 Apr 2009 03:33:00 +0000</pubDate>
		<dc:creator>infogossips</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Prevention]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://be82d129fe6942e43efcb7e2fdc688ae</guid>
		<description><![CDATA[Another study supports others in saying that the benefits of taking lutein include the prevention of age related <b>macular degeneration</b>. <b>Macular degeneration</b> can be caused by other things. But, when it occurs late in life, it is, <b>...</b>]]></description>
			<content:encoded><![CDATA[Another study supports others in saying that the benefits of taking lutein include the prevention of age related <b>macular degeneration</b>. <b>Macular degeneration</b> can be caused by other things. But, when it occurs late in life, it is, <b>...</b>]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/3408/medicines-remedies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Investing In Biotechnology : ITECS Insider</title>
		<link>http://www.curemaculardegeneration.com/8990/investing-in-biotechnology-itecs-insider/</link>
		<comments>http://www.curemaculardegeneration.com/8990/investing-in-biotechnology-itecs-insider/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Glaucoma]]></category>
		<category><![CDATA[Implantable]]></category>
		<category><![CDATA[Insider]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Staphylococcus]]></category>
		<category><![CDATA[Vaccines]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://ead7e65214a9e9f0eab1ff06ede4b0c1</guid>
		<description><![CDATA[Another has a microscopic device implantable in the eye that would continuously release medicines to alleviate glaucoma or <b>macular degeneration</b>. Other companies have developed potential vaccines against staphylococcus infections and ...]]></description>
			<content:encoded><![CDATA[Another has a microscopic device implantable in the eye that would continuously release medicines to alleviate glaucoma or <b>macular degeneration</b>. Other companies have developed potential vaccines against staphylococcus infections and ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/8990/investing-in-biotechnology-itecs-insider/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Potentia Pharmaceuticals and Alcon Research sign license and &#8230;</title>
		<link>http://www.curemaculardegeneration.com/9802/potentia-pharmaceuticals-and-alcon-research-sign-license-and/</link>
		<comments>http://www.curemaculardegeneration.com/9802/potentia-pharmaceuticals-and-alcon-research-sign-license-and/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>SomaNews</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[Alcon Pharmaceuticals]]></category>
		<category><![CDATA[amd]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Licensing Agreements]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Option Agreements]]></category>
		<category><![CDATA[Potentia Pharmaceuticals]]></category>
		<category><![CDATA[Purchase Option]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://6d392f9844f00dbc4767d9e1c3599b03</guid>
		<description><![CDATA[Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced today that it has entered into licensing and purchase option agreements with ...]]></description>
			<content:encoded><![CDATA[Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related <b>macular degeneration</b> (AMD), announced today that it has entered into licensing and purchase option agreements with ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/9802/potentia-pharmaceuticals-and-alcon-research-sign-license-and/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>drabhishekmukherjeehomeopathy&amp;health.blogspot.com: ALL YOU WANTED &#8230;</title>
		<link>http://www.curemaculardegeneration.com/11960/drabhishekmukherjeehomeopathyhealth-blogspot-com-all-you-wanted/</link>
		<comments>http://www.curemaculardegeneration.com/11960/drabhishekmukherjeehomeopathyhealth-blogspot-com-all-you-wanted/#comments</comments>
		<pubDate>Wed, 31 Dec 1969 23:59:59 +0000</pubDate>
		<dc:creator>Abhi</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[age related macular degeneration]]></category>
		<category><![CDATA[amd]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[Beta Carotene]]></category>
		<category><![CDATA[Blogspot]]></category>
		<category><![CDATA[C Beta]]></category>
		<category><![CDATA[Eye Disease]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[macular degeneration]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Vitamin C]]></category>
		<category><![CDATA[Vitamin E]]></category>
		<category><![CDATA[Zinc]]></category>

		<guid isPermaLink="false">tag:blogsearch.google.com://f508b651937b8064a5a817ec2c100450</guid>
		<description><![CDATA[Treating an eye disease called age-related <b>macular degeneration</b> (AMD) when used with other medicines. Taking vitamin E by mouth in combination with vitamin C, beta-carotene and zinc might slow the worsening of advanced age-related ...]]></description>
			<content:encoded><![CDATA[Treating an eye disease called age-related <b>macular degeneration</b> (AMD) when used with other medicines. Taking vitamin E by mouth in combination with vitamin C, beta-carotene and zinc might slow the worsening of advanced age-related ...]]></content:encoded>
			<wfw:commentRss>http://www.curemaculardegeneration.com/11960/drabhishekmukherjeehomeopathyhealth-blogspot-com-all-you-wanted/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
